Rectal Solution
Active ingredients
100 ml contain: Active ingredients: monosodium phosphate monohydrate 16.10 g; disodium phosphate heptahydrate 6 g. Excipients: purified water F.U. q.s. Excipients with known effect: sodium methyl p-hydroxybenzoate 0.104 g. For the full list of excipients, see section 6.1.
Excipients
Sodium methyl p-hydroxybenzoate Purified water F.U.
Therapeutic indications
Constipation. Bowel evacuation before radiological examinations or other diagnostic tests.
Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Anorectal disorders.
Dosage
Dosage Administered rectally only. Adults: 1 bottle of ENEMAC per day. Children over 2 years: half or a quarter of the adult dose. Do not exceed the recommended doses. Method of administration Remove the screw cap and screw on the enclosed cannula. Lubricate the cannula with a few drops of ENEMAC, lie on your left side and gently insert it into the rectum. Squeeze the bottle to release the liquid and extract it while holding it down. Hold the liquid in a supine position until it reaches the desired volume. there is no urgent need to evacuate (about 5 minutes): it is not necessary to hold it for more than 10–15 minutes.
Warnings and precautions
In children over two years of age, the cannula should not penetrate more than half its length. In cold weather, it is advisable to bring the product to room temperature by heating it in a bain-marie. Use occasionally. Do not use in children under two years of age unless under medical supervision. Continued use of laxatives can cause addiction or other types of damage. Do not use laxatives if abdominal pain, nausea, or vomiting are present. If constipation is persistent, consult your doctor. Prolonged use can lead to dehydration. The product contains sodium salts in the quantities indicated above; this information is not available in children under two years of age. should be taken into account in case of a low-sodium diet.
Interactions
No interactions with other drugs have been reported so far.
Side effects
Prolonged use may lead to dehydration. The patient is advised to inform their doctor or pharmacist of the onset of any side effects that may occur during use. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.
Pregnancy and breastfeeding
Use during pregnancy is not contraindicated.
Product Code:FRCM046260
Price Trend
This product has been on sale since 25/09/2017
In the last 30 days, the product's lowest price
was 2,2 €
Richiedi info sul prodotto
